These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36380175)

  • 1. Evaluation of standardized uptake value on
    Sato T; Matsutomo N; Yamamoto T; Fukami M; Kono T
    Ann Nucl Med; 2023 Feb; 37(2):89-98. PubMed ID: 36380175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
    Yen RF; Wu VC; Liu KL; Cheng MF; Wu YW; Chueh SC; Lin WC; Wu KD; Tzen KY; Lu CC;
    J Nucl Med; 2009 Oct; 50(10):1631-7. PubMed ID: 19759122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 131I-6β-iodomethyl-19-norcholesterol adrenal scintigraphy as an alternative to adrenal venous sampling in differentiating aldosterone-producing adenoma from bilateral idiopathic hyperaldosteronism.
    Saiga A; Yokota H; Nagano H; Sawada K; Kubota Y; Wada T; Horikoshi T; Tanaka T; Uno T
    Nucl Med Commun; 2020 Dec; 41(12):1226-1233. PubMed ID: 32956247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan.
    Wu MH; Liu FH; Lin KJ; Sun JH; Chen ST
    Nucl Med Commun; 2019 Jun; 40(6):568-575. PubMed ID: 30694876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for subtyping primary aldosteronism.
    Yang YH; Chang YL; Lee BC; Lu CC; Wang WT; Hu YH; Liu HW; Lin YH; Chang CC; Wu WC; Tseng FY; Lin YH; Wu VC; Hwu CM
    J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S114-S124. PubMed ID: 37202237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of adrenal gland x-ray computed tomography and scintigraphy using radiolabelled norcholesterol in the etiological diagnosis of primary hyperaldosteronism].
    Abram M; Peltier P; Murat A; Chupin M; Dupas B; Gaillard F; Chatal JF; Charbonnel B
    Rev Med Interne; 1993; 14(7):691-7. PubMed ID: 8191071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of Adrenal Iodine-131 6-Beta-Iodomethyl-19-Norcholesterol Scintigraphy for the Subtyping of Primary Aldosteronism.
    Araujo-Castro M; Paja Fano M; González Boillos M; Pascual-Corrales E; García Cano AM; Parra Ramírez P; Martín Rojas-Marcos P; Vicente Delgado A; Casteràs A; Puig A; García Sanz I; Díaz Guardiola P; Robles Lázaro C; Núñez MAS; Guerrero-Vázquez R; Del Castillo Tous M; Michalopoulou Alevras T; Tenes Rodrigo S; Hanzu FA
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.
    Lu CC; Wu VC; Wu KD; Liu KL; Lin WC; Cheng MF; Tzen KY; Yen RF;
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1375-84. PubMed ID: 24525587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
    Magill SB; Raff H; Shaker JL; Brickner RC; Knechtges TE; Kehoe ME; Findling JW
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1066-71. PubMed ID: 11238487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenocortical SPECT using iodine-131 NP-59.
    Hwang I; Balingit AG; Georgitis WJ; Sisson JC; Shapiro B
    J Nucl Med; 1998 Aug; 39(8):1460-3. PubMed ID: 9708530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series.
    Lee J; Ha J; Lee SK; Park HL; Kim SH; Lim DJ; Lee JM; Chang SA; Kang MI; Kim MH
    Int J Gen Med; 2021; 14():673-680. PubMed ID: 33688238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism.
    Gross MD; Shapiro B; Grekin RJ; Meyers L; Swanson DP; Beierwaltes WH
    J Clin Endocrinol Metab; 1983 Sep; 57(3):477-81. PubMed ID: 6874887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of adrenal maximum standardized uptake value to
    Nakajo M; Jinguji M; Tani A; Yoshiura T
    Eur J Radiol; 2020 Dec; 133():109397. PubMed ID: 33190101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning.
    Mansoor GA; Malchoff CD; Arici MH; Karimeddini MK; Whalen GF
    Am J Hypertens; 2002 May; 15(5):459-64. PubMed ID: 12022249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
    Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
    Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of adrenal tumors and hyperplasia in patients with primary aldosteronism: comparison of scintigraphy, CT, and MR imaging.
    Ikeda DM; Francis IR; Glazer GM; Amendola MA; Gross MD; Aisen AM
    AJR Am J Roentgenol; 1989 Aug; 153(2):301-6. PubMed ID: 2665450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
    Gordon L; Levine JH; Mayfield RK; Buse MG
    J Nucl Med; 1979 Aug; 20(8):897-8. PubMed ID: 541739
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.
    Freitas JE; Grekin RJ; Thrall JH; Gross MD; Swanson DP; Beierwaltes WH
    J Nucl Med; 1979 Jan; 20(1):7-10. PubMed ID: 430181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies.
    Radin DR; Manoogian C; Nadler JL
    AJR Am J Roentgenol; 1992 Mar; 158(3):553-7. PubMed ID: 1738993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of CT-based energy imaging to discriminate dominant side lesions in primary aldosteronism.
    Huang M; Yang D; Zhang Y; Zhang Y; Mu Y
    Front Endocrinol (Lausanne); 2023; 14():1121388. PubMed ID: 37124744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.